pentobarbital will minimize the level or outcome of capivasertib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Solid or moderate CYP3A inducers decrease capivasertib publicity, which may minimize efficacy.pentobarbital will decrease the extent or effect of linagliptin by affecting hepatic/intestinal